These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 15734959

  • 1. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion.
    Molden T, Kraus I, Karlsen F, Skomedal H, Nygård JF, Hagmar B.
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):367-72. PubMed ID: 15734959
    [Abstract] [Full Text] [Related]

  • 2. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B.
    Int J Cancer; 2005 May 10; 114(6):973-6. PubMed ID: 15645423
    [Abstract] [Full Text] [Related]

  • 3. Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.
    Kraus I, Molden T, Holm R, Lie AK, Karlsen F, Kristensen GB, Skomedal H.
    J Clin Microbiol; 2006 Apr 10; 44(4):1310-7. PubMed ID: 16597856
    [Abstract] [Full Text] [Related]

  • 4. Comparison of HPV detection technologies: Hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens.
    Keegan H, Mc Inerney J, Pilkington L, Grønn P, Silva I, Karlsen F, Bolger N, Logan C, Furuberg L, O'Leary J, Martin C.
    J Virol Methods; 2009 Jan 10; 155(1):61-6. PubMed ID: 18955086
    [Abstract] [Full Text] [Related]

  • 5. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 6. High-risk human papillomavirus (hrHPV) E6/E7 mRNA testing by PreTect HPV-Proofer for detection of cervical high-grade intraepithelial neoplasia and cancer among hrHPV DNA-positive women with normal cytology.
    Rijkaart DC, Heideman DA, Coupe VM, Brink AA, Verheijen RH, Skomedal H, Karlsen F, Morland E, Snijders PJ, Meijer CJ.
    J Clin Microbiol; 2012 Jul 01; 50(7):2390-6. PubMed ID: 22553244
    [Abstract] [Full Text] [Related]

  • 7. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer.
    Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, Giede C, Lear A.
    J Clin Microbiol; 2010 Aug 01; 48(8):2779-85. PubMed ID: 20573862
    [Abstract] [Full Text] [Related]

  • 8. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
    Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL.
    Cancer; 2002 Apr 15; 94(8):2199-210. PubMed ID: 12001118
    [Abstract] [Full Text] [Related]

  • 9. Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications.
    Varnai AD, Bollmann M, Bankfalvi A, Speich N, Schmitt C, Griefingholt H, Kovács K, Klozoris C, Bollmann R.
    Oncol Rep; 2008 Feb 15; 19(2):457-65. PubMed ID: 18202795
    [Abstract] [Full Text] [Related]

  • 10. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia.
    Tropé A, Sjøborg K, Eskild A, Cuschieri K, Eriksen T, Thoresen S, Steinbakk M, Laurak V, Jonassen CM, Westerhagen U, Jacobsen MB, Lie AK.
    J Clin Microbiol; 2009 Aug 15; 47(8):2458-64. PubMed ID: 19535524
    [Abstract] [Full Text] [Related]

  • 11. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types.
    Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M.
    Cancer Cytopathol; 2013 Dec 15; 121(12):675-87. PubMed ID: 23881840
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus detection by PCR assay in a large series of high-grade squamous intraepithelial lesions with cytohistological correlation and follow-up.
    Lerma Puertas E, Otal Salaverri C, Ríos Martín JJ, Sánchez Gómez A, Jiménez Caraballo A, González-Cámpora R.
    Acta Cytol; 2011 Dec 15; 55(5):426-32. PubMed ID: 21986169
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test.
    Benevolo M, Vocaturo A, Caraceni D, French D, Rosini S, Zappacosta R, Terrenato I, Ciccocioppo L, Frega A, Giorgi Rossi P.
    J Clin Microbiol; 2011 Jul 15; 49(7):2643-50. PubMed ID: 21525231
    [Abstract] [Full Text] [Related]

  • 14. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening].
    Wang JJ, Dong J, Deng ZX, Wang PF, Zhang XX, Du Y.
    Zhonghua Fu Chan Ke Za Zhi; 2019 May 25; 54(5):301-306. PubMed ID: 31154710
    [Abstract] [Full Text] [Related]

  • 15. DNA- versus RNA-based methods for human papillomavirus detection in cervical neoplasia.
    Lie AK, Risberg B, Borge B, Sandstad B, Delabie J, Rimala R, Onsrud M, Thoresen S.
    Gynecol Oncol; 2005 Jun 25; 97(3):908-15. PubMed ID: 15943992
    [Abstract] [Full Text] [Related]

  • 16. Role of high-risk human papillomavirus (HPV) mRNA testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia.
    Tropé A, Jonassen CM, Sjøborg KD, Nygård M, Dahl FA, Alfsen GC, Lie AK.
    Gynecol Oncol; 2011 Nov 25; 123(2):257-62. PubMed ID: 21839500
    [Abstract] [Full Text] [Related]

  • 17. Prognostic implication of high risk human papillomavirus E6 and E7 mRNA in patients with intraepithelial lesions of the cervix in relationship to age.
    Frega A, Lorenzon L, Giovagnoli MR, De Sanctis L, Fabiano V, Lukic A, Moscarini M, Torrisi MR, French D.
    Int J Immunopathol Pharmacol; 2011 Nov 25; 24(2):461-70. PubMed ID: 21658320
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus mRNA and DNA testing in women with atypical squamous cells of undetermined significance: A prospective cohort study.
    Thomsen LT, Dehlendorff C, Junge J, Waldstrøm M, Schledermann D, Frederiksen K, Kjaer SK.
    Int J Cancer; 2016 Oct 15; 139(8):1839-50. PubMed ID: 27004595
    [Abstract] [Full Text] [Related]

  • 19. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S.
    Coll Antropol; 2010 Mar 15; 34(1):19-24. PubMed ID: 20432728
    [Abstract] [Full Text] [Related]

  • 20. Determination of features indicating progression in atypical squamous cells with undetermined significance: human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples.
    Bollmann R, Méhes G, Torka R, Speich N, Schmitt C, Bollmann M.
    Cancer; 2003 Apr 25; 99(2):113-7. PubMed ID: 12704691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.